HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Zhou Selected Research

bimolane

2/2020Chronic myeloid leukaemia in a patient with psoriasis following bimolane treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Zhou Research Topics

Disease

105Neoplasms (Cancer)
04/2024 - 01/2000
36Infections
04/2024 - 01/2000
22Breast Neoplasms (Breast Cancer)
12/2021 - 05/2000
21Inflammation (Inflammations)
01/2021 - 02/2001
18Neoplasm Metastasis (Metastasis)
04/2024 - 10/2001
17Carcinogenesis
06/2022 - 04/2000
14Fibrosis (Cirrhosis)
04/2024 - 07/2001
11Lung Neoplasms (Lung Cancer)
10/2022 - 04/2000
11Necrosis
10/2019 - 05/2000
10Stomach Neoplasms (Stomach Cancer)
11/2023 - 10/2012
10Lymphatic Metastasis
10/2023 - 10/2012
9Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2000
8Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 07/2007
8Colorectal Neoplasms (Colorectal Cancer)
05/2020 - 11/2011
8Chronic Hepatitis B
01/2018 - 07/2001
8Hypoxia (Hypoxemia)
11/2016 - 05/2000
7Body Weight (Weight, Body)
03/2023 - 10/2000
7Chronic Obstructive Pulmonary Disease (COPD)
03/2023 - 04/2006
7Infarction (Infarctions)
08/2022 - 07/2006
7Squamous Cell Carcinoma of Head and Neck
08/2022 - 01/2016
7Ischemia
02/2019 - 05/2000
7Leukemia
01/2018 - 12/2001
6Pneumonia (Pneumonitis)
07/2023 - 01/2011
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2022 - 11/2014
6Obesity
04/2022 - 02/2013
6Rupture
12/2020 - 01/2001
6Hypertension (High Blood Pressure)
06/2020 - 09/2001
6Pre-Eclampsia (Preeclampsia)
03/2020 - 01/2000
6Reperfusion Injury
02/2019 - 01/2000
6Parkinson Disease (Parkinson's Disease)
03/2016 - 01/2000
6Nasopharyngeal Carcinoma
09/2015 - 09/2000
6Type 2 Diabetes Mellitus (MODY)
12/2014 - 09/2008
5Carcinoma (Carcinomatosis)
01/2022 - 05/2000
5Colonic Neoplasms (Colon Cancer)
10/2021 - 01/2006
5Esophageal Neoplasms (Esophageal Cancer)
08/2021 - 01/2002
5Diabetic Nephropathies (Diabetic Nephropathy)
07/2021 - 08/2013
5Measles
07/2021 - 08/2016
5Wounds and Injuries (Trauma)
06/2020 - 08/2012
5Prostatic Neoplasms (Prostate Cancer)
01/2020 - 03/2013
5Glioma (Gliomas)
03/2017 - 02/2011
5Hepatitis
12/2001 - 01/2000
4Sepsis (Septicemia)
10/2023 - 02/2017
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2023 - 02/2009
4Pathologic Constriction (Stenosis)
12/2021 - 03/2014
4Rubella (German Measles)
07/2021 - 08/2016
4Adenocarcinoma
05/2021 - 05/2000
4Osteosarcoma (Osteogenic Sarcoma)
01/2021 - 12/2001
4Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 07/2001
4Multiple Myeloma
11/2020 - 01/2001
4Coronary Disease (Coronary Heart Disease)
10/2020 - 06/2007
4Thrombosis (Thrombus)
06/2020 - 06/2002
4Tuberculosis (Tuberculoses)
03/2020 - 12/2008
4Stroke (Strokes)
01/2020 - 02/2008

Drug/Important Bio-Agent (IBA)

50Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2000
19Messenger RNA (mRNA)IBA
04/2024 - 10/2000
15Long Noncoding RNAIBA
09/2023 - 09/2015
15CytokinesIBA
01/2023 - 01/2001
15AntigensIBA
11/2021 - 04/2000
13Glucose (Dextrose)FDA LinkGeneric
09/2023 - 10/2001
13Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2001
12MicroRNAs (MicroRNA)IBA
08/2019 - 08/2012
11VaccinesIBA
01/2023 - 08/2000
11Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 10/2001
10DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2000
9Therapeutic UsesIBA
03/2023 - 01/2000
9Indicators and Reagents (Reagents)IBA
12/2022 - 09/2000
9EnzymesIBA
11/2021 - 01/2000
9Immunoglobulin G (IgG)IBA
07/2021 - 09/2000
9Interleukin-6 (Interleukin 6)IBA
10/2020 - 12/2000
8InterleukinsIBA
10/2020 - 01/2001
7CollagenIBA
04/2024 - 08/2000
6Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2023 - 01/2002
6AntibodiesIBA
07/2021 - 04/2006
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 01/2000
6Transforming Growth Factors (Transforming Growth Factor)IBA
10/2020 - 01/2002
5RNA (Ribonucleic Acid)IBA
04/2024 - 12/2001
5LipidsIBA
04/2022 - 09/2001
5Anti-Bacterial Agents (Antibiotics)IBA
02/2021 - 06/2017
5Cisplatin (Platino)FDA LinkGeneric
01/2021 - 09/2010
5SolutionsIBA
01/2018 - 01/2011
5Paclitaxel (Taxol)FDA LinkGeneric
09/2017 - 05/2014
5Peptides (Polypeptides)IBA
01/2017 - 09/2001
5Insulin (Novolin)FDA Link
01/2017 - 10/2001
5ParaffinIBA
09/2015 - 03/2001
4salicylhydroxamic acid (SHAM)IBA
10/2023 - 11/2000
4GemcitabineFDA Link
01/2023 - 09/2012
4oxidized low density lipoproteinIBA
04/2022 - 12/2014
4Rituximab (Mabthera)FDA Link
12/2021 - 08/2013
4Hormones (Hormone)IBA
12/2021 - 09/2000
4Phosphotransferases (Kinase)IBA
10/2021 - 04/2000
4ImmunosorbentsIBA
07/2021 - 05/2009
4LigandsIBA
01/2021 - 09/2010

Therapy/Procedure

51Therapeutics
01/2024 - 01/2000
20Drug Therapy (Chemotherapy)
11/2023 - 06/2000
8Radiotherapy
11/2021 - 09/2000
5Lymph Node Excision (Lymph Node Dissection)
11/2023 - 07/2014
5Immunotherapy
11/2023 - 04/2000
5Punctures
10/2023 - 04/2010
5Ligation
10/2023 - 10/2011
4Adjuvant Chemotherapy
11/2023 - 11/2018